Chemo-Pharma [CPL] vs Visa Steel [VISASTEEL] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Chemo-Pharma Laboratories Inc. wins in 11 metrics, Visa Steel Ltd. wins in 7 metrics, with 0 ties. Chemo-Pharma Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemo-Pharma Laboratories Inc. Visa Steel Ltd. Better
P/E Ratio (TTM) 13.22 0.14 Visa Steel Ltd.
Price-to-Book Ratio 2.69 -0.35 Chemo-Pharma Laboratories Inc.
Debt-to-Equity Ratio 48.02 -1.67 Chemo-Pharma Laboratories Inc.
PEG Ratio 0.42 -0.03 Chemo-Pharma Laboratories Inc.
EV/EBITDA 13.60 86.51 Chemo-Pharma Laboratories Inc.
Profit Margin (TTM) 6.53% -94.10% Chemo-Pharma Laboratories Inc.
Operating Margin (TTM) 11.52% -2.59% Chemo-Pharma Laboratories Inc.
EBITDA Margin (TTM) 11.52% N/A N/A
Return on Equity 20.97% 37.96% Visa Steel Ltd.
Return on Assets (TTM) 11.26% -96.84% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $41.66M $130.51M Visa Steel Ltd.
1-Year Return -5.34% 34.29% Visa Steel Ltd.
Price-to-Sales Ratio (TTM) 1.31 1.03 Visa Steel Ltd.
Enterprise Value $5.40B $27.10B Visa Steel Ltd.
EV/Revenue Ratio 1.52 4.90 Chemo-Pharma Laboratories Inc.
Gross Profit Margin (TTM) 24.93% 31.42% Visa Steel Ltd.
Revenue per Share (TTM) $62 $48 Chemo-Pharma Laboratories Inc.
Earnings per Share (Diluted) $5.81 $-43.31 Chemo-Pharma Laboratories Inc.
Beta (Stock Volatility) 0.28 1.09 Chemo-Pharma Laboratories Inc.

Chemo-Pharma Laboratories Inc. vs Visa Steel Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%
Visa Steel Ltd.-0.13%-10.42%-16.32%17.35%-15.18%-27.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%
Visa Steel Ltd.34.29%228.81%287.86%152.85%-32.29%51.33%

Performance & Financial Health Analysis: Chemo-Pharma Laboratories Inc. vs Visa Steel Ltd.

MetricCPLVISASTEEL
Market Information
Market Cap i₹4.62B₹6.02B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i97,70057,826
90 Day Avg. Volume i68,66134,401
Last Close₹70.50₹39.90
52 Week Range₹52.67 - ₹87.75₹27.05 - ₹73.68
% from 52W High-19.66%-45.85%
All-Time High₹128.00 (Jan 06, 2025)₹73.68 (Oct 17, 2025)
% from All-Time High-44.92%-45.85%
Growth Metrics
Quarterly Revenue Growth0.40%0.28%
Quarterly Earnings Growth0.41%0.22%
Financial Health
Profit Margin (TTM) i0.07%-0.94%
Operating Margin (TTM) i0.12%-0.03%
Return on Equity (TTM) i0.21%0.38%
Debt to Equity (MRQ) i48.02-1.67
Cash & Liquidity
Book Value per Share (MRQ)₹28.58₹-119.16
Cash per Share (MRQ)₹0.05₹1.74
Operating Cash Flow (TTM) i₹277.99M₹-539,980,000
Levered Free Cash Flow (TTM) i₹313.23M₹-5,165,500,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00₹0.00

Valuation & Enterprise Metrics Analysis: Chemo-Pharma Laboratories Inc. vs Visa Steel Ltd.

MetricCPL (Apr 26, 2026)VISASTEEL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i13.220.14
Forward P/E iN/AN/A
PEG Ratio i0.42-0.03
Price to Sales (TTM) i1.311.03
Price to Book (MRQ) i2.69-0.35
Market Capitalization
Market Capitalization i₹4.62B₹6.02B
Enterprise Value i₹5.40B₹27.10B
Enterprise Value Metrics
Enterprise to Revenue i1.524.90
Enterprise to EBITDA i13.6086.51
Risk & Other Metrics
Beta i0.281.09
Book Value per Share (MRQ) i₹28.58₹-119.16

Financial Statements Comparison: Chemo-Pharma Laboratories Inc. vs Visa Steel Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCPL (2025)VISASTEEL (2025)
Revenue/Sales i2.85B5.44B
Cost of Goods Sold i2.07B3.78B
COGS % of Revenue i72.6%69.4%
Gross Profit i778.98M1.67B
Gross Margin i27.4%30.6%
Research & Development iN/AN/A
Operating Income (EBIT) i300.69M-173.80M
Operating Margin i10.6%-3.2%
EBITDA i353.29M322.10M
EBITDA Margin i12.4%5.9%
Pre-Tax Income i392.47M-5.17B
Pre-Tax Income % of Revenue i13.8%-94.9%
Income Tax i79.24M0
Income Tax % of Revenue i2.8%0.0%
Net Income (Profit) i313.23M-5.17B
Profit Margin i11.0%-94.9%

Balance Sheet & Liquidity Metrics

MetricCPL (2025)VISASTEEL (2025)
Cash & Equivalents i12.05M2.30M
Total Current Assets i2.51B767.91M
Total Current Assets % of Revenue i88.1%14.1%
Total Current Liabilities i1.17B18.56B
Total Current Liabilities % of Revenue i41.2%341.0%
Long-Term Debt i109.50M372.70M
Long-Term Debt % of Revenue i3.8%6.8%
Total Shareholders Equity i1.49B-13.61B
Retained Earnings i1.08B-21.08B
Retained Earnings % of Revenue i37.9%-387.3%
Property, Plant & Equipment i48.61M392.36M

Cash Flow Statement Comparison

MetricCPL (2025)VISASTEEL (2025)
Operating Cash Flow i277.99M-539.98M
Operating Cash Flow % of Revenue i9.8%-9.9%
Capital Expenditures i-47.82M-124.77M
Free Cash Flow i41.66M130.51M
FCF Margin i1.5%2.4%
Debt Repayment i-359.80M-30.14M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCPLVISASTEEL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i60.18M145.79M
Float Shares i17.41M7.78M
% Held by Insiders i69.98%74.60%
% Held by Institutions i0.00%7.40%
% Held by Public i30.02%18.00%

Dividend Analysis & Yield Comparison: Chemo-Pharma Laboratories Inc. vs Visa Steel Ltd.

MetricCPLVISASTEEL
Last 12-Month Dividend i₹0.00₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00₹0.00
Ex-Dividend DateN/AN/A